8-K

UNITEDSTATES

SECURITIESAND EXCHANGE COMMISSION

Washington,D.C. 20549

FORM8-K

CURRENTREPORT

Pursuantto Section 13 OR 15(d) of the Securities Exchange Act of 1934

Retractable Technologies, Inc.

(Exact name of registrant as specified in its charter)

None

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

On April 30, 2020, the Company issued a press release, a copy of which is attached to this Form 8-K as Exhibit 99, announcing a change to the date of the annual shareholders’ meeting.

(d) Exhibits

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Exhibit 99

RETRACTABLE TECHNOLOGIES, INC.REPORTS CHANGE TO MEETING DATE

LITTLE ELM, Texas, April 30, 2020—Retractable Technologies, Inc. (NYSE American: RVP) (the “Company”) today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic, and related health and travel concerns, the date of the 2020 annual meeting of shareholders of Retractable Technologies, Inc. (the “Annual Meeting”) has been changed to June 22, 2020 at 10:00 a.m. The adjourned meeting is expected to be held at Little Elm Town Hall located at 100 West Eldorado Parkway, Little Elm, Texas 75068. However, the Company has also secured a vendor to assist in facilitating a virtual meeting on June 22, 2020 if an in-person meeting is still not advisable due to COVID-19 concerns. If the format of the meeting is changed to a virtual meeting, a notice will be distributed by press release.

A notice regarding the change to the date of the Annual Meeting (the “Notice”) is being filed with the Securities and Exchange Commission together with this press release. Additional information regarding the Annual Meeting, shareholder participation and voting is provided in the Notice.

The Company manufactures and markets VanishPoint^®^ and Patient Safe^®^ safety medical products and the EasyPoint^®^ needle. The VanishPoint^®^ syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe^®^ syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint^®^ is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint^®^ needle also can be used to aspirate fluids and for blood collection. The Company’s products are distributed by various specialty and general line distributors.

For more information on Retractable Technologies, Inc., visit its website at www.retractable.com.

Retractable Technologies, Inc.

John W. Fort III, 888-806-2626 or 972-294-1010

Vice President and Chief Financial Officer